Qube Research & Technologies (QRT)
KRON

Qube Research & Technologies (QRT)’s Kronos Bio KRON Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-297
Closed -$368 – 3748
2024
Q2 		$368 Hold
297
– – ﹤0.01% 3336
2024
Q1 		$386 Sell
297
-1,577
-84% -$1.8K ﹤0.01% 4098
2023
Q4 		$2.34K Sell
1,874
-4,850
-72% -$5.37K ﹤0.01% 3808
2023
Q3 		$8.74K Sell
6,724
-52,709
-89% -$85.2K ﹤0.01% 3349
2023
Q2 		$102K Buy
+59,433
New +$94.4K ﹤0.01% 1945
2021
Q3 		– Sell
-8,912
Closed -$213K – 2514
2021
Q2 		$213K Sell
8,912
-2,372
-21% -$60K ﹤0.01% 1761
2021
Q1 		$330K Buy
+11,284
New +$331K 0.01% 1412

Other funds holding KRON

VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.83B AUM 20.31% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Qube Research & Technologies (QRT)'s KRON Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Kronos Bio (KRON) in Q3 2024, closing a stake of 297 shares — an estimated $368 sold.

Qube Research & Technologies (QRT) first reported a position in KRON in Q1 2021 and held it in 7 quarters. The position peaked at $330K in Q1 2021. 53 funds tracked by Wall St. Rank hold KRON as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Kronos Bio position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 297 Kronos Bio shares in Q3 2024, an estimated $368.
  • Qube Research & Technologies (QRT) first reported a position in Kronos Bio in Q1 2021 and held it in 7 quarters.
  • Qube Research & Technologies (QRT)'s Kronos Bio position peaked at $330K in Q1 2021.
  • 53 funds tracked by Wall St. Rank held Kronos Bio as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.